{"id":353818,"date":"2019-04-11T01:45:03","date_gmt":"2019-04-11T01:45:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=353818"},"modified":"2019-04-11T01:45:03","modified_gmt":"2019-04-11T01:45:03","slug":"next-generation-cancer-diagnostics-2019-global-trends-market-size-share-status-swot-analysis-and-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/next-generation-cancer-diagnostics-2019-global-trends-market-size-share-status-swot-analysis-and-forecast-to-2025_353818.html","title":{"rendered":"Next Generation Cancer Diagnostics 2019 Global Trends, Market Size, Share, Status, SWOT Analysis and Forecast to 2025"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Next Generation Cancer Diagnostics Market”<\/div>\n<\/div>\n<\/div>\n
WiseGuyRerports.com Presents \u201cGlobal Next Generation Cancer Diagnostics Market Size, Status and Forecast 2019-2025\u201d New Document to its Studies Database<\/div>\n

 <\/p>\n

In 2018, the global Next Generation Cancer Diagnostics<\/a><\/strong> market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.<\/p>\n

This report focuses on the global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Cancer Diagnostics development in United States, Europe and China.<\/p>\n

The key players covered in this study 
Cepheid 
Koninklijke Philips N.V 
F. Hoffmann-La Roche Ltd 
Qiagen 
Novartis AG 
Abbott 
Thermo Fisher Scientific 
Opko Health 
Myriad Genetics 
Agilent Technologies 
GE Healthcare 
PerkinElmer 
Genomic Health 
Illumina 
Hologic 
Almac Group 
Janssen Global Services 
Sysmex Corporation<\/strong><\/p>\n

 <\/strong><\/p>\n

 Request Free Sample Report<\/strong> @ https:\/\/www.wiseguyreports.com\/sample-request\/3911427-global-next-generation-cancer-diagnostics-market-size-status<\/a>                           <\/p>\n

                                     <\/p>\n

Market segment by Type,<\/strong> the product can be split into 
Next Generation Sequencing 
qPCR & Multiplexing 
DNA Microarrays 
Other<\/p>\n

Market segment by Application<\/strong>, split into 
Hospitals 
Clinics 
Other<\/p>\n

Market segment by Regions\/Countries<\/strong>, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America<\/p>\n

The study objectives of this report are: 
<\/strong>To analyze global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. 
To present the Next Generation Cancer Diagnostics development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.<\/p>\n

 <\/strong><\/p>\n

Complete Report Details @ <\/strong>https:\/\/www.wiseguyreports.com\/reports\/3911427-global-next-generation-cancer-diagnostics-market-size-status<\/a>                   <\/p>\n

 <\/p>\n

Table Of Contents:      <\/strong><\/p>\n

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
<\/strong>1.4.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (2014-2025) 
1.4.2 Next Generation Sequencing 
1.4.3 qPCR & Multiplexing 
1.4.4 DNA Microarrays 
1.4.5 Other 
1.5 Market by Application 
<\/strong>1.5.1 Global Next Generation Cancer Diagnostics Market Share by Application (2014-2025) 
1.5.2 Hospitals 
1.5.3 Clinics 
1.5.4 Other 
1.6 Study Objectives 
1.7 Years Considered<\/strong><\/p>\n

2 Global Growth Trends 
<\/strong>2.1 Next Generation Cancer Diagnostics Market Size 
2.2 Next Generation Cancer Diagnostics Growth Trends by Regions 
2.2.1 Next Generation Cancer Diagnostics Market Size by Regions (2014-2025) 
2.2.2 Next Generation Cancer Diagnostics Market Share by Regions (2014-2019) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities<\/p>\n

….<\/strong><\/p>\n

12 International Players Profiles 
12.1 Cepheid 
<\/strong>12.1.1 Cepheid Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Next Generation Cancer Diagnostics Introduction 
12.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2014-2019) 
12.1.5 Cepheid Recent Development 
12.2 Koninklijke Philips N.V 
<\/strong>12.2.1 Koninklijke Philips N.V Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Next Generation Cancer Diagnostics Introduction 
12.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2014-2019) 
12.2.5 Koninklijke Philips N.V Recent Development 
12.3 F. Hoffmann-La Roche Ltd 
<\/strong>12.3.1 F. Hoffmann-La Roche Ltd Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Next Generation Cancer Diagnostics Introduction 
12.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2014-2019) 
12.3.5 F. Hoffmann-La Roche Ltd Recent Development 
12.4 Qiagen 
<\/strong>12.4.1 Qiagen Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Next Generation Cancer Diagnostics Introduction 
12.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2014-2019) 
12.4.5 Qiagen Recent Development 
12.5 Novartis AG 
<\/strong>12.5.1 Novartis AG Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Next Generation Cancer Diagnostics Introduction 
12.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2014-2019) 
12.5.5 Novartis AG Recent Development <\/p>\n

 <\/p>\n

 Continued…….<\/strong>                                                      <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com<\/a>
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

 <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Next Generation Cancer Diagnostics Market” WiseGuyRerports.com Presents \u201cGlobal Next Generation Cancer Diagnostics Market Size, Status and Forecast 2019-2025\u201d New Document to its Studies Database   In 2018, the global Next Generation Cancer Diagnostics market size was million US$ and it … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-353818","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/353818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=353818"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/353818\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=353818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=353818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=353818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}